AFM-Téléthon and The Muscular Dystrophy Association (MDA) are proud to announce the awarding of two cutting-edge research grants to accelerate the development of treatments for mitochondrial myopathies and amyotrophic lateral sclerosis (ALS).
“This partnership with MDA is an essential step to build a strong collaboration between our two associations, through the support of these two promising projects,” said Jean-François Briand, PhD, Operations and Scientific Innovation Director, AFM-Telethon. “They both explore different RNA involvement in rare diseases that will open the way to new therapeutic development not only for these diseases but also for other ones.”
